KITE PHARMA INC's ticker is KITE and the CUSIP is 49803L109. A total of 161 filers reported holding KITE PHARMA INC in Q3 2015. The put-call ratio across all filers is 0.60 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $465,000 | -27.7% | 9,300 | -33.6% | 0.16% | -11.3% |
| Q1 2016 | $643,000 | -50.3% | 14,000 | -33.4% | 0.18% | -38.5% |
| Q4 2015 | $1,294,000 | -10.6% | 21,007 | -19.2% | 0.29% | -1.4% |
| Q3 2015 | $1,448,000 | +89.8% | 26,007 | +107.9% | 0.29% | +49.7% |
| Q2 2015 | $763,000 | +10.1% | 12,507 | +4.2% | 0.20% | +4.8% |
| Q1 2015 | $693,000 | -39.9% | 12,007 | -40.0% | 0.19% | -5.1% |
| Q4 2014 | $1,154,000 | +145.5% | 20,007 | +21.2% | 0.20% | +102.1% |
| Q3 2014 | $470,000 | – | 16,507 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wildcat Capital Management, LLC | 2,410,034 | $433,348,000 | 77.71% |
| COWEN INC. | 4,200,600 | $755,310,000 | 26.72% |
| Tyrus Capital S.A.M. | 1,314,812 | $236,416,000 | 18.49% |
| OMNI PARTNERS LLP | 661,711 | $118,982,000 | 15.19% |
| FNY Partners Fund LP | 379,510 | $68,239,000 | 11.61% |
| EQUITEC PROPRIETARY MARKETS, LLC | 240,100 | $43,172,000 | 10.15% |
| EQUITEC PROPRIETARY MARKETS, LLC | 227,500 | $40,907,000 | 9.62% |
| GARDNER LEWIS ASSET MANAGEMENT L P | 773,817 | $139,140,000 | 8.89% |
| Quad Capital Management Advisors LLC | 192,537 | $34,620,000 | 7.10% |
| Avoro Capital Advisors LLC | 496,983 | $89,363,000 | 6.93% |